1) Overall Survival£¨OS£©
2) Median Overall Survival£¨mOS£©
3) Disease Free Survival£¨DFS£©
4) Median Disease Free Survival£¨mDFS£©
5) Progress Free Survival£¨PFS£©
6) Time To Progress£¨TTP£©
7) Objective Response Rate£¨ORR£©
8) Complete Response£¨CR£©
9) Partial Response£¨PR£©
10) Stable Disease£¨SD£©
11) Disease Control Rate£¨DCR£©
12) Duration of Response£¨DOR£©
13) Time To Failure£¨TTF£©
14) Duration of Disease Control£¨DDC£©
1) reactive capillary hemangiomas
2) thyroid related adverse events
3) Hypophysitis
4) Adrenal insufficiency
5) Hyperglycemia
6) Immune associated pneumonia
7) Immune associated diarrhea
8) Immune associated colitis
9) Immune associated hepatitis
10) Immune associated glomerulonephritis
11) Immune associated pancreatitis
12) Immune associated thrombocytopenia
13) Immune related myocarditis
14) Immune related skin adverse reactions
15) anemia
16) fever
17) fatigue
18) proteinuria
19) cough
20) loss of appetite
21) hyponatremia
22) pulmonary infection
23) increase of aspartate aminotransferase
24) increase of ¦Ã¨Cglutamyltransferase
25) increase of blood bilirubin
26) increase of conjugated bilirubin
27) abnormal liver function
28) decrease of neutrophil count
29) decrease of leukocyte count
30) decrease of platelet count
31) decrease of lymphocyte count
32) hypokalemia
33) increase of alanine aminotransferase
34) increase of blood alkaline phosphatase
35) increase of lipase